Belpointe Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-286	Closed	-$1.57K	–	3463
2023 Q1	$1.57K	Hold	286	–	–	﹤0.01%	3378
2022 Q4	$1.31K	Buy	+286	New	+$1.31K	﹤0.01%	3380